MultiStem

BIOLOGICAL6 trials

Sponsors

Healios K.K., Prof. Dr. Marc-H. Dahlke, Ph. D.

Conditions

ARDSAcute Respiratory Distress SyndromeAdult Stem CellsIschemic StrokeLiver TransplantationTrauma

Phase 1

Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation

TerminatedNCT01841632

Prof. Dr. Marc-H. Dahlke, Ph. D.Liver Transplantation

Start: 2013-04-30End: 2016-12-31Updated: 2018-08-17

A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome

CompletedNCT02611609

Healios K.K.Acute Respiratory Distress Syndrome

Start: 2016-01-31End: 2019-07-31Updated: 2019-11-20

Phase 2

Study to Examine the Effects of MultiStem in Ischemic Stroke

CompletedNCT01436487

Healios K.K.Ischemic Stroke

Start: 2011-10-31End: 2015-12-31Updated: 2016-08-02

MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)

TerminatedNCT04367077

Healios K.K.ARDS

Start: 2020-04-28End: 2024-10-01Updated: 2026-08-11

MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome

RecruitingNCT04533464

Healios K.K.Adult Stem Cells, Trauma

Start: 2020-11-09End: 2025-12-31Target: 156Updated: 2024-05-24

Phase 3

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study

TerminatedNCT03545607

Healios K.K.Ischemic Stroke

Start: 2018-07-28End: 2024-10-01Updated: 2026-08-11

Related Papers

Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020

Translational Medicine Communications2021-11-0314 citations

Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.

2017-03-17269 citations